Tong Maomeng
Executive Director @ INCE Capital
Tong Maomeng is a Series A investor at INCE Capital focused on Biopharma and Biotechnology. Tong Maomeng is the Executive Director of Yingce Capital.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Tong Maomeng invests in
Stages Tong Maomeng invests in
Countries Tong Maomeng invests in
Investment Focus
Industry
- Biopharma 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Brise Pharma
|
Brise Pharma operates in the scientific research and technical service industry. | $28.1M / Series A / Nov 11, 2025 |
Co-Investors
Qiming Venture Partners
2 deals together
Beijing Medical and Health Industry Investment Fund
1 deal together
Prox Ventures
1 deal together
Shunxi Fund
1 deal together
About INCE Capital
INCE Capital is a new fund that will invest in early-stage consumer-related technology companies in China.
INCE Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
JP Gan
Founding Partner
|
|||
Steven Hu
Founding Partner
|
|||
|
Tong Maomeng
Executive Director
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Tong Maomeng invest in?
Tong Maomeng invests primarily in Biopharma, Biotechnology and Pharmaceutical startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Tong Maomeng last invest?
The most recent investment recorded for Tong Maomeng closed in Nov 2025. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
